The number of women in the present study with a first-degree family history of breast cancer who tested negative for BRCA1/BRCA2 mutations (71 cases, 27 controls) does not offer adequate power to detect differences in the frequency of CHEK2 variants within this stratification. This evidence concerns the gene CHEK2 and breast cancer.